Kathryn C. Zoon - Jun 9, 2022 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
Director
Signature
/s/ Brian Millard, Attorney-in-fact
Stock symbol
EBS
Transactions as of
Jun 9, 2022
Transactions value $
-$36,973
Form type
4
Date filed
6/13/2022, 04:16 PM
Previous filing
May 31, 2022
Next filing
May 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Sale -$37K -1.17K -5.63% $31.52 19.7K Jun 9, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.